Utilization of dietary vitamin K supplementation to aid in INR stabilization for patients on chronic oral anticoagulant therapy: a series of case reports

被引：0
|
作者：
L. Earl
R. Pena
J. Hutchinson
机构：
[1] University of New Mexico Hospital,
[2] Lovelace Healthcare System,undefined
[3] Holy Cross Hospital,undefined
来源：
Journal of Thrombosis and Thrombolysis | 2008年 / 25卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：91 / 91
相关论文
共 50 条
  • [11] Development of a Tool to Identify Patients' Preference for Vitamin K Antagonist or Direct Oral Anticoagulant Therapy
    Zolfaghari, Shabnam
    Harenberg, Job
    Froelich, Lutz
    Wehling, Martin
    Weiss, Christel
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (01): : 121 - 128
  • [12] A meta-summary of case reports of non-vitamin K antagonist oral anticoagulant use in patients with left ventricular thrombus
    Aloysius Sheng-Ting Leow
    Ching-Hui Sia
    Benjamin Yong-Qiang Tan
    Joshua Ping-Yun Loh
    Journal of Thrombosis and Thrombolysis, 2018, 46 : 68 - 73
  • [13] Stroke severity in patients with preceding direct oral anticoagulant therapy as compared to vitamin K antagonists
    Auer, Elias
    Frey, Sebastien
    Kaesmacher, Johannes
    Hakim, Arsany
    Seiffge, David J.
    Goeldlin, Martina
    Arnold, Marcel
    Fischer, Urs
    Jung, Simon
    Meinel, Thomas Raphael
    JOURNAL OF NEUROLOGY, 2019, 266 (09) : 2263 - 2272
  • [14] Stroke severity in patients with preceding direct oral anticoagulant therapy as compared to vitamin K antagonists
    Elias Auer
    Sebastién Frey
    Johannes Kaesmacher
    Arsany Hakim
    David J. Seiffge
    Martina Goeldlin
    Marcel Arnold
    Urs Fischer
    Simon Jung
    Thomas Raphael Meinel
    Journal of Neurology, 2019, 266 : 2263 - 2272
  • [15] Adherence to oral anticoagulant therapy in patients with atrial fibrillation Focus on non-vitamin K antagonist oral anticoagulants
    Raparelli, Valeria
    Proietti, Marco
    Cangemi, Roberto
    Lip, Gregory Y. H.
    Lane, Deirdre A.
    Basili, Stefania
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (02) : 209 - 218
  • [16] THROMBIN GENERATION (TG) POTENTIAL AND ACTIVATED PROTEIN C (APC) RESISTANCE IN PATIENTS ON CHRONIC ORAL ANTICOAGULANT THERAPY WITH VITAMIN K ANTAGONIST (VKA)
    Verzeroli, C.
    Marchetti, M.
    Giaccherini, C.
    Milesi, V.
    Barcella, L.
    Falanga, A.
    HAEMATOLOGICA, 2015, 100 : 625 - 625
  • [17] Characteristics of Symptomatic Intracranial Hemorrhage in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulant Therapy
    Akiyama, Hisanao
    Uchino, Kenji
    Hasegawa, Yasuhiro
    PLOS ONE, 2015, 10 (07):
  • [18] Warfarin control in patients transitioning to warfarin after non-vitamin K oral anticoagulant (NOAC) therapy
    Nijole Bernaitis
    Tony Badrick
    Andrew K. Davey
    Julia Crilly
    Shailendra Anoopkumar-Dukie
    Journal of Thrombosis and Thrombolysis, 2018, 46 : 461 - 465
  • [19] Warfarin control in patients transitioning to warfarin after non-vitamin K oral anticoagulant (NOAC) therapy
    Bernaitis, Nijole
    Badrick, Tony
    Davey, Andrew K.
    Crilly, Julia
    Anoopkumar-Dukie, Shailendra
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 46 (04) : 461 - 465
  • [20] Oral Anticoagulant Therapy and Bleeding Events with Vitamin K Antagonists in Patients with Atrial Fibrillation in a Hungarian County Hospital
    Mark, Laszlo
    Dani, Gyozo
    Vendrey, Robert
    Paragh, Gyoergy
    Katona, Andras
    MEDICAL SCIENCE MONITOR, 2015, 21 : 518 - 525
12345